Literature DB >> 8352286

Presymptomatic testing for Huntington disease in the United States.

K A Quaid.   

Abstract

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction; Huntington Disease Testing Committee

Mesh：

Year:  1993        PMID： 8352286      PMCID： PMC1682434     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  7 in total

1.  Reluctance to undergo predictive testing: the case of Huntington disease.

Authors:  Kimberly A Quaid; Michael Morris
Journal:  Am J Med Genet       Date:  1993

2.  Canadian experience with predictive testing for Huntington disease: lessons for genetic testing centers and policy makers.

Authors:  M A Chapman
Journal:  Am J Med Genet       Date:  1992-02-15

3.  The ethical justification for minimal paternalism in the use of the predictive test for Huntington's disease.

Authors:  D DeGrazia
Journal:  J Clin Ethics       Date:  1991

4.  Ethical issues policy statement on Huntington's disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology.

Authors:  L Went
Journal:  J Med Genet       Date:  1990-01       Impact factor: 6.318

5.  Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.

Authors:  M Huggins; M Bloch; S Wiggins; S Adam; O Suchowersky; M Trew; M Klimek; C R Greenberg; M Eleff; L P Thompson
Journal:  Am J Med Genet       Date:  1992-02-15

6.  Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk.

Authors:  M Bloch; S Adam; S Wiggins; M Huggins; M R Hayden
Journal:  Am J Med Genet       Date:  1992-02-15

7.  Duty to disclose in medical genetics: a legal perspective.

Authors:  M Z Pelias
Journal:  Am J Med Genet       Date:  1991-06-01
  7 in total
  5 in total

1.  Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.

Authors:  A C DudokdeWit; A Tibben; H J Duivenvoorden; M F Niermeijer; J Passchier
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

2.  Selection for presymptomatic testing for Huntington's disease: who decides?

Authors:  J Binedell; J R Soldan; P S Harper
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

3.  A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.

Authors:  E W Almqvist; M Bloch; R Brinkman; D Craufurd; M R Hayden
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

Review 4.  A comprehensive review of spinocerebellar ataxia type 2 in Cuba.

Authors:  Luis Velázquez-Pérez; Roberto Rodríguez-Labrada; Julio Cesar García-Rodríguez; Luis Enrique Almaguer-Mederos; Tania Cruz-Mariño; José Miguel Laffita-Mesa
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

Review 5.  Presymptomatic testing for genetic diseases of later life. Pharmacoepidemiological considerations.

Authors:  B J Rossiter; C T Caskey
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.